{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:58:02Z","timestamp":1779321482427,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":1063,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1908209"],"award-info":[{"award-number":["U1908209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170385"],"award-info":[{"award-number":["82170385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1908209"],"award-info":[{"award-number":["U1908209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170385"],"award-info":[{"award-number":["82170385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Heart failure with mildly reduced ejection fraction (HFmrEF) has received increasing attention following the publication of the latest ESC guidelines in 2021. However, it remains unclear whether patients with HFmrEF could benefit from guideline-directed medical treatment (GDMT), referring the combination of ACEI\/ARB\/ARNI, \u03b2-blockers, and MRAs, which are recommended for those with reduced ejection fraction. This study explored the efficacy of GDMT in HFmrEF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective cohort study of HFmrEF patients admitted to The First Affiliated Hospital of Dalian Medical University between 1 September 2015 and 30 November 2019. Propensity score matching (1:2) between patients receiving triple-drug therapy (TT) and non-triple therapy (NTT) based on age and sex was performed. The primary outcome was all cause death, cardiac death, rehospitalization from any cause, and rehospitalization due to worsening heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 906 patients enrolled in the matched cohort (TT group, n = 302; NTT group, N = 604), 653 (72.08%) were male, and mean age was 61.1 \u00b1 11.92. Survival analysis suggested that TT group experienced a significantly lower incidence of prespecified primary endpoints than NTT group. Multivariable Cox regression showed that TT group had a lower risk of all-cause mortality (HR 0.656, 95% CI 0.447\u20130.961, P = 0.030), cardiac death (HR 0.599, 95% CI 0.380\u20130.946, P = 0.028), any-cause rehospitalization (HR 0.687, 95% CI 0.541\u20130.872, P = 0.002), and heart failure rehospitalization (HR 0.732, 95% CI 0.565\u20130.948, P = 0.018).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with HFmrEF, combined use of neurohormonal antagonists produces remarkable effects in reducing the occurrence of the primary outcome of rehospitalization and death. Thus, the treatment of HFmrEF should be categorized as HFrEF due to the similar benefit of neurohormonal blocking therapy in HFrEF and HFmrEF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14199","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T08:37:37Z","timestamp":1671093457000},"page":"1035-1042","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Guideline-Directed Medical Treatment in Heart Failure with Mildly Reduced Ejection Fraction"],"prefix":"10.1093","volume":"10","author":[{"given":"Xinxin","family":"Zhang","sequence":"first","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxi","family":"Sun","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]},{"name":"Department of Cardiology, West China Hospital, Sichuan University , Chengdu, Sichuan Province, 610041 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing ChaoYang Hospital, Capital Medical University , Beijing, 100020 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyan","family":"Sha","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songqi","family":"Yu","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lv","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijie","family":"Ding","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Tse","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]},{"name":"Kent and Medway Medical School , Canterbury, Kent, CT2 7NT ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Heart Failure and Structural Cardiology Ward, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning Province, 116021 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"2026012114111311400_ehf214199-bib-0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114111311400_ehf214199-bib-0002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ejhf.159","article-title":"The middle child in heart failure: Heart failure with mid-range ejection fraction (40-50%)","volume":"16","author":"Lam","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0003","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","article-title":"Mechanisms and models in heart failure: The biomechanical model and beyond","volume":"111","author":"Mann","year":"2005","journal-title":"Circulation"},{"key":"2026012114111311400_ehf214199-bib-0004","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure - digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"2026012114111311400_ehf214199-bib-0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-018-0757-3","article-title":"How heart rate should be controlled in patients with atherosclerosis and heart failure","volume":"20","author":"da Silva","year":"2018","journal-title":"Curr Atheroscler Rep"},{"key":"2026012114111311400_ehf214199-bib-0006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ejhf.932","article-title":"Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: A propensity-score matched study","volume":"20","author":"Gayat","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0007","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.jacc.2019.03.478","article-title":"ACC\/AHA versus ESC guidelines on heart failure: JACC guideline comparison","volume":"73","author":"van der Meer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012114111311400_ehf214199-bib-0008","article-title":"Hospitalization and mortality in patients with heart failure treated with sacubitril\/valsartan vs. enalapril: A real-world, population-based study","volume":"7","author":"Pathadka","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2026012114111311400_ehf214199-bib-0009","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012114111311400_ehf214199-bib-0010","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"2026012114111311400_ehf214199-bib-0011","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s00392-015-0877-5","article-title":"Effects of spironolactone on ventricular-arterial coupling in patients with chronic systolic heart failure and mild symptoms","volume":"104","author":"Vizzardi","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"2026012114111311400_ehf214199-bib-0012","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10741-018-9689-9","article-title":"Is there a blood pressure lowering effect of MRAs in heart failure? An overview and meta-analysis","volume":"23","author":"Bazoukis","year":"2018","journal-title":"Heart Fail Rev"},{"key":"2026012114111311400_ehf214199-bib-0013","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.656536","article-title":"Predictive value of HFA-PEFF score in patients with heart failure with preserved ejection fraction","volume":"8","author":"Sun","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026012114111311400_ehf214199-bib-0014","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1002\/ehf2.13630","article-title":"Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction","volume":"8","author":"Zhang","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0015","article-title":"Heart failure with midrange ejection fraction: Prior left ventricular ejection fraction and prognosis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026012114111311400_ehf214199-bib-0016","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/ehf2.13187","article-title":"Predictive value of H2 FPEF score in patients with heart failure with preserved ejection fraction","volume":"8","author":"Sun","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0017","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1002\/ehf2.12929","article-title":"Multi-modality machine learning approach for risk stratification in heart failure with left ventricular ejection fraction &lt;\/= 45","volume":"7","author":"Tse","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0018","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ejhf.807","article-title":"Characterization of heart failure patients with mid-range left ventricular ejection fraction-A report from the CHART-2 Study","volume":"19","author":"Tsuji","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0019","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00392-016-1063-0","article-title":"Acute heart failure with mid-range left ventricular ejection fraction: Clinical profile, in-hospital management, and short-term outcome","volume":"106","author":"Farmakis","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2026012114111311400_ehf214199-bib-0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00874","article-title":"Novel mechanisms in heart failure with preserved, midrange, and reduced ejection fraction","volume":"10","author":"Lakhani","year":"2019","journal-title":"Front Physiol"},{"key":"2026012114111311400_ehf214199-bib-0021","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012114111311400_ehf214199-bib-0022","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026012114111311400_ehf214199-bib-0023","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ejhf.496","article-title":"Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012","volume":"18","author":"Thorvaldsen","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0024","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ejhf.945","article-title":"A comprehensive population-based characterization of heart failure with mid-range ejection fraction","volume":"19","author":"Koh","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114111311400_ehf214199-bib-0026","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012114111311400_ehf214199-bib-0027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"Solomon","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114111311400_ehf214199-bib-0028","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ehf2.12635","article-title":"Mineralocorticoid receptor antagonist use following heart failure hospitalization","volume":"7","author":"Duran","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114111311400_ehf214199-bib-0029","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2020.07.008","article-title":"Sympathetic activation and outcomes in chronic heart failure: Does the neurohormonal hypothesis apply to mid-range and preserved ejection fraction patients?","volume":"81","author":"Jimenez-Marrero","year":"2020","journal-title":"Eur J Intern Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14199","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14199","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/2\/1035\/65051239\/eschf_10_2_1035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/2\/1035\/65051239\/eschf_10_2_1035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:12:27Z","timestamp":1769022747000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/2\/1035\/8304869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,12,15]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14199","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"2022-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}